(Q35925610)
Statements
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib (English)
Keiryn L Bennett
Uwe Rix
Tilmann Bürckstümmer
Uwe Schmidt
Michael Kneidinger
Gregor Schütze
7 August 2007
1 reference
1 reference